Schedule 13G ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Common Stock · CUSIP: N62509109

Event date: 2025-09-30

Filing-level shares
9,822,711.00
Percent of class
8.7%
  • Capital World Investors

    Shares: 9,822,711.00 · Class: 8.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-25-000077
Form type
SCHEDULE 13G/A
Filer
Capital World Investors
CIK
CIK 1422849
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub